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Introduction {#bjs550263-sec-0006}
============

In 2004, the Japan Society for Endoscopic Surgery (JSES) introduced the Endoscopic Surgical Skill Qualification System (ESSQS)[1](#bjs550263-bib-0001){ref-type="ref"}, [2](#bjs550263-bib-0002){ref-type="ref"}, [3](#bjs550263-bib-0003){ref-type="ref"} to maintain and improve the quality of laparoscopic surgery. Candidacy for the ESSQS requires academic achievements (3 conference presentations and 2 papers on laparoscopic surgery), laparoscopic experience (including 20 advanced procedures such as colorectal resection and gastrectomy, or 50 basic procedures such as cholecystectomy and inguinal hernia repair), attendance at JSES official training seminars, and 2 years of general surgical experience after the board certification by the Japan Surgical Society. The examination is based on anonymized unedited random video review and scoring by two or three expert laparoscopic surgeons designated by the JSES. ESSQS‐certified surgeons in the colorectal surgery section are qualified to perform sigmoidectomies for colonic cancer and high anterior resections for rectosigmoid cancer.

Only 20--30 per cent of ESSQS examinees are considered adequate for qualification each year, and currently less than 10 per cent of Japanese general surgeons are ESSQS‐certified. Still, it remains unclear whether technically qualified surgeons could safely perform procedures after ESSQS certification. It has been reported that mentoring and tutoring by an ESSQS‐qualified surgeon are efficient methods for teaching laparoscopic colorectal surgical skills[4](#bjs550263-bib-0004){ref-type="ref"}, and that supervision by an ESSQS‐certified surgeon affects the safety of laparoscopic colectomy performed by a junior surgeon[5](#bjs550263-bib-0005){ref-type="ref"}. However, no large study has investigated whether this qualification can actually improve the safety of the laparoscopic resections.

This study aimed to evaluate the impact of the ESSQS certification on the safety and oncological outcomes of laparoscopic colorectal resections.

Methods {#bjs550263-sec-0007}
=======

All laparoscopic colorectal resections performed from January 2010 to December 2013 in Hokkaido University Hospital and ten affiliated hospitals were reviewed retrospectively. Inclusion criteria for the study were stage 0, I, II or III confirmed adenocarcinoma of the colon or rectum. Patients who had other synchronous or metachronous cancers (excluding *in situ* cancer) within 5 years and had undergone chemotherapy or radiotherapy before surgery were excluded.

The ethics committees of Hokkaido University Hospital and all participating hospitals approved this study. Informed consent was obtained from all patients, in accordance with the guidelines of the Japanese Ministry of Health, Labour and Welfare.

For each patient, data extracted from records included: clinical features, demographics, presentation, surgical data, postoperative outcome and follow‐up.

Procedures were categorized according to whether they were performed by surgeons with or without the ESSQS qualification, and patients\' clinical, pathological and surgical features were used to match subgroups using propensity scoring.

Outcome measures {#bjs550263-sec-0008}
----------------

Groups were compared for differences in short‐ and long‐term outcomes. Short‐term results included: duration of surgery, blood loss, conversion rate, intraoperative complication rate (defined as injury to major vessels, intestinal tract or surrounding organs, or another intraoperative accidental event), postoperative complication rate, reoperation rate, length of postoperative hospital stay, number of harvested lymph nodes, and R0 resection rate. Postoperative complications were assessed according to the Clavien--Dindo classification[6](#bjs550263-bib-0006){ref-type="ref"}. Follow‐up was conducted in day clinics. The 5‐year overall recurrence‐free and local recurrence‐free rates (defined as the time from surgery to recurrence or local recurrence) were compared in patients with pathological stage II and III cancers. In addition, the association between overall and local recurrence and intervention by ESSQS‐qualified or unqualified surgeon was examined in patients with stage II and III cancer.

Statistical analysis {#bjs550263-sec-0009}
--------------------

Continuous data are reported as mean values with 95 per cent confidence intervals. All statistical tests were performed using an α level of 0·05 (two‐sided). χ^2^ and Student\'s *t* tests were used for categorical and non‐normal continuous data respectively.

The following clinical, surgical and pathological features were selected as factors for propensity score matching: age, sex, BMI, ASA fitness grade, previous laparotomy, obstruction, cT status, cN status, clinical stage, procedure, anastomosis, lymph node dissection (D1, D2 or D3) and diverting stoma. Propensity scores were generated using multivariable logistic regression models with attendance of ESSQS‐qualified surgeons as the outcome.

Survival curves for the studied groups were estimated using the Kaplan--Meier method and compared with the log rank test. Cox regression with co‐variable adjustment was performed separately for patients with stage II and those with stage III disease, with selected prognostic values (attendance of ESSQS‐qualified surgeon, rectal cancer, age, sex, primary tumour size and depth, lymph node metastasis, extent of lymph node dissection, BMI, ASA grade, occurrence of postoperative complication, R status, tumour differentiation, adjuvant chemotherapy, and lymph and venous vessel invasion of the primary lesion). Simple linear regression was performed to assess the relationship between institutional heterogeneity (number of beds, annual volume of colorectal cancer surgery, number of surgeons, and the proportion of operations performed or attended by ESSQS‐qualified surgeons in each institution) and the rate of postoperative complications.

All statistical analyses were performed using JMP® Pro version 14.0 (SAS Institute, Cary, North Carolina, USA).

Results {#bjs550263-sec-0010}
=======

A total of 1428 laparoscopic colorectal procedures that met the inclusion criteria were performed in 2010--2013, including 586 procedures performed with or by ESSQS‐qualified surgeons and 842 procedures performed by non‐ESSQS‐qualified surgeons. Seven ESSQS‐qualified surgeons attended 177, 154, 143, 102, seven, two and one operation respectively. Each ESSQS‐qualified surgeon contributed as an operator (312 operations), assistant (260) or endoscopist (14) (*Fig*. [1](#bjs550263-fig-0001){ref-type="fig"}).

![Patient flow diagram ESSQS, Endoscopic Surgical Skill Qualification System.](BJS5-4-486-g001){#bjs550263-fig-0001}

Institutional characteristics are summarized in *Table*  [1](#bjs550263-tbl-0001){ref-type="table"}. The mean number of beds was 507·0 and a mean of 519·5 and 92·0 annual cases of general surgery and colorectal surgery were identified, respectively. The mean number of attending surgeons was 6·7 and the rate of laparoscopic surgery for colorectal cancers was 48·9 per cent. There was no correlation between the proportion of operations attended by ESSQS‐qualified surgeons and institutional volume (number of beds: R^2^ = 0.08, *P* = 0.397; general surgery volume: R^2^ = 0.10, *P* = 0.334; colorectal surgery volume: R^2^ = 0.06, *P* = 0.515).

###### 

Characteristics of the 11 institutions

  Institution    \% of operations attended by ESSQS‐qualified surgeons   No. of beds   No. of surgeons   Annual no. of colorectal operations   \% of colorectal operations done laparoscopically   No. of registered patients
  ------------- ------------------------------------------------------- ------------- ----------------- ------------------------------------- --------------------------------------------------- ----------------------------
  A                                       97                                 944              5                          47                                           75                                       92
  B                                      71·3                                519             14                          172                                         44·6                                     254
  C                                       88                                 382              5                          74                                           78                                      155
  D                                        0                                 747              8                          98                                           42                                      160
  E                                        3                                 539             10                          145                                         40·5                                     133
  F                                      13·6                                410              5                          91                                           50                                      132
  G                                      47·0                                358              4                          64                                           51                                      115
  H                                       100                                498              4                          65                                           51                                      102
  I                                        0                                 300              6                          65                                           43                                       99
  J                                        0                                 430              5                          81                                           38                                       97
  K                                        1                                 450              8                          110                                         24·4                                      89
  Mean                                   38·3                               507·0            6·7                        92·0                                         48·9                                    129·8

ESSQS, Endoscopic Surgical Skill Qualification System.

Patient characteristics are summarized in *Table*  [2](#bjs550263-tbl-0002){ref-type="table"}. A total of 337 men and 249 women with a mean age of 67·6 years were treated in the ESSQS group, and 474 men and 368 women with a mean age of 68·5 years had surgery performed by non‐ESSQS‐qualified surgeons. No differences in BMI or history of previous surgery were observed between the two groups. The frequency of preoperative co‐morbidity with ASA grade III or above was higher in the ESSQS group than in the non‐ESSQS group (13·5 *versus* 8·2 per cent respectively; *P* = 0·013). In addition, 3·4 and 1·8 per cent of patients in the ESSQS and non‐ESSQS groups respectively had a preoperative obstruction due to the tumour that required decompression (*P* = 0·049). The ESSQS group had more patients who underwent rectal resection (295 (50·3 per cent) *versus* 341 (40·5 per cent); *P* \< 0·001) and D3 lymph node dissection (67·1 *versus* 60·9 per cent; *P* = 0·007) than the non‐ESSQS group. The types of colonic anastomosis and the frequency of double‐stapling technique using linear and circular staplers in the entire cohort were different between the two groups. Moreover, combined resection of surrounding organs was performed significantly more in the ESSQS group (2·0 *versus* 0·6 per cent; *P* = 0·025). Surrounding organs involved in combined resections included the small bowel (5), uterus and its adnexa (3), ureter (1) and bladder (3) in the ESSQS group and small bowel (2), uterus and its adnexa (2) and bladder (1) in the non‐ESSQS group.

###### 

Patient characteristics

                                                                           ESSQS group (*n* = 586)   Non‐ESSQS group (*n* = 842)   *P* [‡](#bjs550263-note-0005){ref-type="fn"}
  ----------------------------------------------------------------------- ------------------------- ----------------------------- ----------------------------------------------
  **Age (years)** [\*](#bjs550263-note-0003){ref-type="fn"}                   67·6 (66·7--68·5)           68·5 (67·8--69·3)                           0·143§
  **Sex ratio (M** : **F)**                                                       337 : 249                   474 : 368                               0·649
  **BMI (kg/m** ^**2**^ **)** [\*](#bjs550263-note-0003){ref-type="fn"}       23·1 (22·9--23·5)           23·0 (22·7--23·3)                           0·427§
  **ASA fitness grade III--IV**                                                   79 (13·5)                   69 (8·2)                                0·013
  **Previous laparotomy**                                                        144 (24·6)                  209 (24·8)                               0·915
  **Obstruction**                                                                 20 (3·4)                    15 (1·8)                                0·049
  **Tumour location**                                                                                                                                 0·046
  Colon                                                                          390 (66·6)                  602 (71·5)           
  Rectum                                                                         196 (33·4)                  240 (28·5)           
  **cT category**                                                                                                                                     0·136
  cT0                                                                             27 (4·6)                    36 (4·3)            
  cT1                                                                            152 (25·9)                  197 (23·4)           
  cT2                                                                            108 (18·4)                  159 (18·9)           
  cT3                                                                            272 (46·4)                  383 (45·5)           
  cT4                                                                             27 (4·6)                    67 (8·0)            
  **cN category**                                                                                                                                     0·002
  cN0                                                                            481 (82·1)                  633 (75·2)           
  cN1                                                                             77 (13·1)                  172 (20·4)           
  cN2                                                                             25 (4·3)                    36 (4·3)            
  cN3                                                                              3 (0·5)                     1 (0·1)            
  **Clinical stage**                                                                                                                                  0·021
  0                                                                               27 (4·6)                    36 (4·3)            
  I                                                                              249 (42·5)                  323 (38·4)           
  II                                                                             205 (35·0)                  274 (32·5)           
  III                                                                            105 (17·7)                  209 (24·8)           
  **Procedure**†                                                                                                                                     \< 0·001
  Right colectomy                                                                154 (26·3)                  284 (33·7)           
  Transverse colectomy                                                            33 (5·6)                    35 (4·2)            
  Left colectomy                                                                  21 (3·6)                    31 (3·7)            
  Sigmoidectomy                                                                   78 (13·3)                  149 (17·7)           
  High anterior resection                                                        157 (26·8)                  182 (21·6)           
  Low anterior resection                                                         101 (17·2)                  147 (17·5)           
  Hartmann procedure                                                              13 (2·2)                      0 (0)             
  ISR                                                                              3 (0·5)                      0 (0)             
  APR                                                                             21 (3·6)                    12 (1·4)            
  Total coloproctectomy                                                            3 (0·5)                     2 (0·2)            
  **Combined resection**                                                                                                          
  Surrounding organ                                                               12 (2·0)                     5 (0·6)                                0·025
  Multiple procedures                                                             15 (2·6)                    33 (3·9)                                0·160
  **Anastomosis** [†](#bjs550263-note-0004){ref-type="fn"}                                                                                           \< 0·001
  FEEA                                                                           127 (21·7)                  388 (46·1)           
  Triangular                                                                     155 (26·5)                   47 (5·6)            
  Albert--Lembert method                                                            0 (0)                     36 (4·3)            
  Side‐to‐end                                                                      2 (0·3)                    11 (1·3)            
  DST                                                                            258 (44·0)                  328 (39·0)           
  CAA or IAA                                                                       6 (1·0)                      0 (0)             
  **Lymph node dissection** [†](#bjs550263-note-0004){ref-type="fn"}                                                                                  0·007
  D1                                                                              15 (2·6)                    37 (4·4)            
  D2                                                                             178 (30·4)                  287 (34·1)           
  D3                                                                             393 (67·1)                  513 (60·9)           
  **LLND**                                                                         7 (1·2)                     5 (0·6)                                0·353
  **Diverting stoma**                                                             39 (6·7)                    21 (2·5)                               \< 0·001

Values in parentheses are percentages unless indicated otherwise;

values are mean (95 per cent c.i.).

Indicates some missing data. ESSQS, Endoscopic Surgical Skill Qualification System; ISR, intersphincteric resection; APR, abdominoperineal resection; FEEA, functional end‐to‐end anastomosis; DST, double‐stapling technique; CAA, coloanal anastomosis; IAA, ileal J pouch--anal anastomosis; LLND, lateral lymph node dissection.

χ^2^ test, except §Student\'s *t* test.

Short‐term outcomes {#bjs550263-sec-0011}
-------------------

Duration of surgery (230 *versus* 238 min; *P* = 0·045) and postoperative hospital stay (14·5 *versus* 16·3 days; *P* = 0·002) were significantly shorter in the ESSQS group. Intraoperative and postoperative complication rates (grade III or above) were 1·2 and 4·6 per cent respectively in the ESSQS group, and 3·6 and 7·5 per cent in the non‐ESSQS group (*Table*  [3](#bjs550263-tbl-0003){ref-type="table"}). Significant differences in intraoperative accidental bleeding from major vessels and postoperative anastomotic leakage were observed between the groups. The reoperation rate was also significantly lower in the ESSQS group than in the non‐ESSQS group (1·9 *versus* 3·9 per cent; *P* = 0·023), particularly reoperation due to anastomotic leak (0·7 *versus* 2·3 per cent; *P* = 0·035). No differences in conversion rate, blood loss, number of harvested lymph nodes or pathological R0 rate were found (*Table*  [3](#bjs550263-tbl-0003){ref-type="table"}).

###### 

Operative outcomes

                                                                                      ESSQS group (*n* = 586)   Non‐ESSQS group (*n* = 842)   *P* [‡](#bjs550263-note-0009){ref-type="fn"}
  ---------------------------------------------------------------------------------- ------------------------- ----------------------------- ----------------------------------------------
  **Duration of surgery (min)** [\*](#bjs550263-note-0007){ref-type="fn"}                 230 (224--237)              238 (234--244)                             0·045§
  **Blood loss (ml)** [\*](#bjs550263-note-0007){ref-type="fn"}                          51·7 (38·9--64·4)           59·7 (49·0--70·4)                           0·342§
  **Conversion**                                                                             16 (2·7)                    32 (3·8)                                0·270
  **Intraoperative complication**                                                             7 (1·2)                    30 (3·6)                                0·014
  Bleeding                                                                                    1 (0·2)                    13 (1·5)                                0·021
  Injury to intestinal tract                                                                  2 (0·3)                     4 (0·5)                                0·999
  Injury to surrounding organs                                                                3 (0·5)                     8 (1·0)                                0·533
  Other                                                                                       1 (0·2)                     5 (0·6)                                0·424
  **Postoperative complication** [†](#bjs550263-note-0008){ref-type="fn"}                    27 (4·6)                    63 (7·5)                                0·025
  Bleeding                                                                                    3 (0·5)                     3 (0·4)                                0·975
  Superficial SSI                                                                              0 (0)                      3 (0·4)                                0·390
  Deep SSI                                                                                    2 (0·3)                     4 (0·5)                                0·999
  Anastomotic leak                                                                            7 (1·2)                    31 (3·7)                                0·007
  Ileus                                                                                       4 (0·7)                    12 (1·4)                                0·291
  Cardiac, pulmonary or cerebral                                                              3 (0·5)                      0 (0)                                 0·136
  Other                                                                                       8 (1·4)                    10 (1·2)                                0·956
  **Reoperation**                                                                            11 (1·9)                    33 (3·9)                                0·023
  Bleeding                                                                                    1 (0·2)                     2 (0·2)                                0·990
  Deep SSI                                                                                     0 (0)                      1 (0·1)                                0·999
  Anastomotic leak                                                                            4 (0·7)                    19 (2·3)                                0·035
  Ileus                                                                                       3 (0·5)                     4 (0·5)                                0·999
  Other                                                                                       3 (0·5)                     7 (0·8)                                0·697
  **Postoperative hospital stay (days)** [\*](#bjs550263-note-0007){ref-type="fn"}       14·5 (13·6--15·4)           16·3 (15·6--17·1)                           0·002§
  **No. of harvested lymph nodes** [\*](#bjs550263-note-0007){ref-type="fn"}             18·0 (17·2--19·0)           18·3 (17·6--19·1)                           0·681§
  **Pathological R0 resection**                                                             570 (97·3)                  832 (98·8)                               0·099

Values in parentheses are percentages unless indicated otherwise;

values are mean (95 per cent c.i.).

Grade III or above according to the Clavien--Dindo classification. ESSQS, Endoscopic Surgical Skill Qualification System.

χ^2^ test, except §Student\'s *t* test.

For rectal resections, both high and low anterior resections were performed more quickly in the ESSQS group (high anterior resection: mean 222 *versus* 244 min, *P* = 0·001; low anterior resection: 280 *versus* 309 min, *P* = 0·004). Blood loss was also lower in the ESSQS group for low anterior resection (43·0 *versus* 73·7 ml; *P* = 0·039), as were the intraoperative complication (0 *versus* 6·1 per cent; *P* = 0·002) and conversion (2·0 *versus* 6·8 per cent; *P* = 0·066) rates. The intraoperative complication rate for sigmoidectomy performed by ESSQS‐qualified surgeons was lower (0 *versus* 4·7 per cent; *P* = 0·014), as was the reoperation rate for right colectomy (0·6 *versus* 3·5 per cent; *P* = 0·042) (*Table*  [4](#bjs550263-tbl-0004){ref-type="table"}).

###### 

Short‐term outcomes by procedure

                                     ESSQS group (*n* = 586)   Non‐ESSQS group (*n* = 842)   *P* [†](#bjs550263-note-0012){ref-type="fn"}
  --------------------------------- ------------------------- ----------------------------- -----------------------------------------------
  **Duration of surgery (min)**                                                             
  Right colectomy                        204 (195--214)              210 (203--217)          0·353[‡](#bjs550263-note-0013){ref-type="fn"}
  Transverse colectomy                   220 (194--246)              210 (184--235)          0·575[‡](#bjs550263-note-0013){ref-type="fn"}
  Left colectomy                         227 (192--263)              238 (209--266)          0·650[‡](#bjs550263-note-0013){ref-type="fn"}
  Sigmoidectomy                          206 (191--222)              215 (204--227)          0·344[‡](#bjs550263-note-0013){ref-type="fn"}
  High anterior resection                222 (213--232)              244 (235--253)          0·001[‡](#bjs550263-note-0013){ref-type="fn"}
  Low anterior resection                 280 (266--296)              309 (297--322)          0·004[‡](#bjs550263-note-0013){ref-type="fn"}
  **Blood loss (ml)**                                                                       
  Right colectomy                      69·4 (34·2--104·6)           65·5 (39·5--91·5)        0·857[‡](#bjs550263-note-0013){ref-type="fn"}
  Transverse colectomy                  47·7 (19·5--75·7)           34·5 (7·2--61·9)         0·507[‡](#bjs550263-note-0013){ref-type="fn"}
  Left colectomy                       28·2 (−37·6--93·9)          81·4 (33·2--141·5)        0·169[‡](#bjs550263-note-0013){ref-type="fn"}
  Sigmoidectomy                         52·8 (25·8--80·0)           44·1 (24·3--63·8)        0·653[‡](#bjs550263-note-0013){ref-type="fn"}
  High anterior resection               25·8 (11·4--40·2)           40·5 (26·9--54·1)        0·145[‡](#bjs550263-note-0013){ref-type="fn"}
  Low anterior resection                43·0 (20·7--65·4)           73·7 (55·1--92·3)        0·039[‡](#bjs550263-note-0013){ref-type="fn"}
  **Intraoperative complication**                                                           
  Right colectomy                        4 of 154 (2·6)              5 of 284 (1·7)                              0·562
  Transverse colectomy                        0 (0)                       0 (0)                                   --
  Left colectomy                              0 (0)                    2 of 31 (6)                               0·235
  Sigmoidectomy                               0 (0)                  7 of 149 (4·7)                              0·014
  High anterior resection                2 of 157 (1·3)              7 of 182 (3·8)                              0·124
  Low anterior resection                      0 (0)                  9 of 147 (6·1)                              0·002
  **Conversion**                                                                            
  Right colectomy                        5 of 154 (3·2)              9 of 284 (3·2)                              0·964
  Transverse colectomy                     2 of 33 (6)                    0 (0)                                  0·139
  Left colectomy                           1 of 21 (5)                 2 of 31 (6)                               0·798
  Sigmoidectomy                            1 of 78 (1)               3 of 149 (2·0)                              0·691
  High anterior resection                3 of 157 (1·9)              7 of 182 (3·8)                              0·276
  Low anterior resection                 2 of 101 (2·0)              10 of 147 (6·8)                             0·066
  **Postoperative complication**                                                            
  Right colectomy                        9 of 154 (5·8)              18 of 284 (6·3)                             0·837
  Transverse colectomy                     1 of 33 (3)                 2 of 35 (6)                               0·590
  Left colectomy                          3 of 21 (14)                3 of 31 (10)                               0·610
  Sigmoidectomy                            2 of 78 (3)               9 of 149 (6·0)                              0·247
  High anterior resection                5 of 157 (3·1)              10 of 182 (5·5)                             0·286
  Low anterior resection                 6 of 101 (5·9)             16 of 147 (10·9)                             0·169
  **Reoperation**                                                                           
  Right colectomy                        1 of 154 (0·6)              10 of 284 (3·5)                             0·042
  Transverse colectomy                        0 (0)                    1 of 35 (3)                               0·246
  Left colectomy                          3 of 21 (14)                3 of 31 (10)                               0·610
  Sigmoidectomy                               0 (0)                  4 of 149 (2·7)                              0·065
  High anterior resection                2 of 157 (1·3)              4 of 182 (2·2)                              0·505
  Low anterior resection                 4 of 101 (4·0)              10 of 147 (6·8)                             0·324

Values in parentheses are percentages unless indicated otherwise;

values are mean (95 per cent c.i.). ESSQS, Endoscopic Surgical Skill Qualification System.

χ^2^ test, except

Student\'s *t* test.

Short‐term outcomes in the propensity score‐matched cohort {#bjs550263-sec-0012}
----------------------------------------------------------

Short‐term outcomes were also compared following propensity score matching. Some 426 patients from each group were included in the matched cohort. After matching, each ESSQS‐qualified surgeon in the ESSQS group contributed as an operator (214), assistant (202) or endoscopist (10). There was no difference between groups for any preoperative factor or procedure (age, sex, BMI, ASA grade, previous laparotomy, obstruction, tumour location, cT and cN status, clinical stage, type of procedure, combined resection, anastomosis, lymph node dissection, lateral lymph node dissection and diverting stoma). Duration of surgery (226 *versus* 249 min; *P* = 0·001) and postoperative hospital stay (13·7 *versus* 17·5 days; *P* \< 0·001) were significantly shorter in the ESSQS group. Intraoperative and postoperative complication rates (grade III or above) were 1·6 and 4·7 per cent respectively in the ESSQS group and 4·2 and 9·9 per cent in the non‐ESSQS group (*Table*  [5](#bjs550263-tbl-0005){ref-type="table"}). Significant differences in intraoperative accidental bleeding from major vessels (0·2 *versus* 1·8 per cent; *P* = 0·021) and postoperative anastomotic leakage (1·4 *versus* 5·2 per cent; *P* = 0·002) were observed between the groups. The reoperation rate was also lower in the ESSQS group than in the non‐ESSQS group (1·6 *versus* 4·9 per cent; *P* = 0·007), particularly that due to anastomotic leakage (0·7 *versus* 3·3 per cent; *P* = 0·014). No differences in conversion rate, blood loss, number of harvested lymph nodes, and pathological R0 rate were found (*Table*  [5](#bjs550263-tbl-0005){ref-type="table"}).

###### 

Patient characteristics and short‐term surgical outcomes in the propensity score‐matched cohort

                                                                           ESSQS group (*n* = 426)   Non‐ESSQS group (*n* = 426)   *P* [†](#bjs550263-note-0016){ref-type="fn"}
  ----------------------------------------------------------------------- ------------------------- ----------------------------- -----------------------------------------------
  **Age (years)** [\*](#bjs550263-note-0015){ref-type="fn"}                   67·4 (66·4--68·5)           67·4 (66·4--58·5)        0·989[‡](#bjs550263-note-0017){ref-type="fn"}
  **Sex ratio (M** : **F)**                                                       247 : 179                   250 : 176                                0·835
  **BMI (kg/m** ^**2**^ **)** [\*](#bjs550263-note-0015){ref-type="fn"}       23·2 (22·9--23·6)           23·0 (22·7--23·4)        0·447[‡](#bjs550263-note-0017){ref-type="fn"}
  **Tumour location**                                                                                                                                  0·310
  Colon                                                                          270 (63·4)                  256 (60·0)           
  Rectum                                                                         156 (36·6)                  170 (40·0)           
  **Clinical stage**                                                                                                                                   0·868
  0                                                                               21 (4·9)                    21 (4·9)            
  I                                                                              185 (43·4)                  173 (40·6)           
  II                                                                             131 (30·8)                  138 (32·4)           
  III                                                                             89 (20·9)                   94 (22·1)           
  **Procedure**                                                                                                                                        0·945
  Right colectomy                                                                110 (25·8)                  111 (26·1)           
  Transverse colectomy                                                            18 (4·2)                    14 (3·3)            
  Left colectomy                                                                  14 (3·3)                     9 (2·1)            
  Sigmoidectomy                                                                   42 (9·9)                    40 (9·4)            
  High anterior resection                                                        142 (33·3)                  149 (35·0)           
  Low anterior resection                                                          88 (20·7)                   91 (21·4)           
  APR                                                                             11 (2·6)                    10 (2·3)            
  Other                                                                            1 (0·2)                     2 (0·5)            
  **Anastomosis**                                                                 *n* = 415                   *n* = 415                                0·537
  FEEA                                                                           125 (30·1)                  125 (30·1)           
  Triangular anastomosis                                                          55 (13·3)                   47 (11·3)           
  DST                                                                            230 (55·4)                  241 (58·1)           
  Other                                                                            5 (1·2)                     2 (0·5)            
  **Lymph node dissection**                                                                                                                            0·956
  D1                                                                              12 (2·8)                    12 (2·8)            
  D2                                                                             133 (31·2)                  129 (30·3)           
  D3                                                                             281 (66·0)                  285 (66·9)           
  **Diverting stoma**                                                             17 (4·0)                    20 (4·7)                                 0·614
  **Outcomes**                                                                                                                    
  Duration of surgery (min)[\*](#bjs550263-note-0015){ref-type="fn"}           226 (219--234)              249 (241--256)          0·001[‡](#bjs550263-note-0017){ref-type="fn"}
  Blood loss (ml)[\*](#bjs550263-note-0015){ref-type="fn"}                    48·7 (35·6--61·8)           57 9 (44·7--71·0)        0·329[‡](#bjs550263-note-0017){ref-type="fn"}
  Conversion                                                                       9 (2·1)                    16 (3·8)                                 0·153
  Intraoperative complication                                                      7 (1·6)                    18 (4·2)                                 0·025
  Postoperative complication                                                      20 (4·7)                    42 (9·9)                                 0·003
  Reoperation                                                                      7 (1·6)                    21 (4·9)                                 0·007
  No. of harvested lymph nodes[\*](#bjs550263-note-0015){ref-type="fn"}       17·5 (16·4--18·6)           18·9 (17·8--20·0)        0·078[‡](#bjs550263-note-0017){ref-type="fn"}
  Pathological R0 resection                                                      416 (97·7)                  420 (98·6)                                0·449

Values in parentheses are percentages unless indicated otherwise;

values are mean (95 per cent c.i.). ESSQS, Endoscopic Surgical Skill Qualification System; APR, abdominoperineal resection; FEEA, functional end‐to‐end anastomosis; DST, double‐stapling technique.

χ^2^ test, except

Student\'s *t* test.

Pathological outcomes and survival {#bjs550263-sec-0013}
----------------------------------

Overall, no differences in tumour depth, node status, pathological stage or tumour size were observed between subgroups. However, the ESSQS group had a higher rate of adenocarcinoma with undifferentiated features (20·0 *versus* 14·4 per cent; *P* = 0·007) (*Table*  [6](#bjs550263-tbl-0006){ref-type="table"}). The rate of lymph vessel invasion in the ESSQS and non‐ESSQS group was 51·0 and 40·6 per cent respectively (*P* \< 0·001), and the venous vessel invasion rate was 51·2 and 41·6 per cent (*P* \< 0·001).

###### 

Pathological features

                                                                           ESSQS group (*n* = 586)   Non‐ESSQS group (*n* = 842)   *P* [†](#bjs550263-note-0020){ref-type="fn"}
  ----------------------------------------------------------------------- ------------------------- ----------------------------- -----------------------------------------------
  **pT category**                                                                                                                 
  pT0                                                                             32 (5·5)                    49 (5·8)                                 0·695
  pT1a                                                                             7 (1·2)                     9 (1·1)            
  pT1b                                                                           140 (23·9)                  180 (21·4)           
  pT2                                                                             95 (16·2)                  163 (19·4)           
  pT3                                                                            269 (45·9)                  382 (45·4)           
  pT4a                                                                            35 (6·0)                    48 (5·7)            
  pT4b                                                                             8 (1·4)                    11 (1·3)            
  **pN category**                                                                                                                 
  pN0                                                                            427 (72·9)                  598 (71·0)                                0·491
  pN1                                                                            122 (20·8)                  199 (23·6)           
  pN2                                                                             31 (5·3)                    40 (4·8)            
  pN3                                                                              6 (1·0)                     5 (0·6)            
  **Pathological stage**                                                                                                          
  0                                                                               39 (6·7)                    49 (5·8)                                 0·784
  I                                                                              213 (36·3)                  300 (35·6)           
  II                                                                             179 (30·5)                  252 (29·9)           
  III                                                                            155 (26·5)                  241 (28·6)           
  **Tumour size (mm)** [\*](#bjs550263-note-0019){ref-type="fn"}              34·5 (32·8--36·2)           34·4 (33·0--35·9)        0·939[‡](#bjs550263-note-0021){ref-type="fn"}
  **No. of metastatic nodes** [\*](#bjs550263-note-0019){ref-type="fn"}       0·79 (0·61--0·98)           0·73 (0·58--0·89)        0·617[‡](#bjs550263-note-0021){ref-type="fn"}
  **Lymph vessel invasion**                                                      299 (51·0)                  342 (40·6)                              \< 0·001
  **Venous vessel invasion**                                                     300 (51·2)                  350 (41·6)                              \< 0·001
  **Differentiated adenocarcinoma**                                              553 (94·4)                  805 (95·6)                                0·287
  **With undifferentiated features**                                             116 (20·0)                  121 (14·4)                                0·007
  **Adjuvant chemotherapy**                                                                                                       
  Stage II                                                                    56 of 179 (31·3)            36 of 252 (14·3)                           \< 0·001
  Stage III                                                                   108 of 155 (69·7)           173 of 241 (71·8)                            0·652

Values in parentheses are percentages unless indicated otherwise;

values are mean (95 per cent c.i.). ESSQS, Endoscopic Surgical Skill Qualification System.

χ^2^ test, except

Student\'s *t* test.

The median length of follow‐up was 60 months for both groups. Of 333 patients in the ESSQS group 31 (9·3 per cent) were lost to follow‐up, and of 492 patients in the non‐ESSQS group 39 (7·9 per cent) were lost to follow‐up (*P* = 0·485). The 5‐year overall recurrence‐free survival rates for patients with stage II--III cancers were 76·1 (95 per cent c.i. 71·0 to 80·6) and 80·5 (76·5 to 83·9) per cent in the ESSQS and non‐ESSQS group respectively (*P* = 0·221) (*Fig*. [2](#bjs550263-fig-0002){ref-type="fig"} *a*).

![Association between intervention by ESSQS‐qualified surgeons and recurrence‐free survival in patients with stage II and III cancers **a** Kaplan--Meier analysis of recurrence‐free survival (RFS) in an unadjusted cohort of patients with stage II and III colorectal cancer operated on by ESSQS‐certified or non‐ESSQS‐qualified surgeons. *P* = 0·221 (log rank test). **b,c** Cox regression analysis of recurrence. Hazard ratios are shown with 95 per cent confidence intervals for each risk factor for patients with stage II (**b**) and stage III (**c**) disease. \**P* \< 0·050. ESSQS, Endoscopic Surgical Skill Qualification System; LND, lymph node dissection; Por, poorly differentiated; Muc, mucinous.](BJS5-4-486-g002){#bjs550263-fig-0002}

In Cox regression analysis for stage II and stage III disease (excluding R2), R1 resection, obstruction, T4 status and venous vessel invasion were significantly associated with recurrence in stage II, whereas obstruction, node status, high ASA grade, lymph vessel invasion, T4 status and rectal cancer were significantly associated with recurrence in stage III. However, attendance of ESSQS‐qualified surgeons was not an independent factor (stage II: hazard ratio (HR) 1·05, 95 per cent c.i. 0·58 to 1·89, *P* = 0·881; stage III: HR 1·07, 0·69 to 1·67, *P* = 0·761) (*Fig*. [2](#bjs550263-fig-0002){ref-type="fig"} *b,c*).

There were eight local recurrences in the ESSQS group and 22 in the non‐ESSQS group. In the ESSQS group, local recurrence occurred in the peritoneum or retroperitoneum around the primary site (4 patients), lesional lymph node (3) and anastomotic site (1), and in the non‐ESSQS group local recurrence was observed in the peritoneum or retroperitoneum around the primary site (16), lesional lymph node (3), anastomotic site (2), and both the peritoneum and anastomotic site (1). The 5‐year overall local recurrence‐free survival rate for pathological stage II--III cancers was 96·9 and 94·6 per cent in the ESSQS and non‐ESSQS group respectively (*P* = 0·092). In Cox regression analysis for stage II and III disease (excluding R2), non‐attendance of ESSQS‐qualified surgeons (HR 12·30, 95 per cent c.i. 1·28 to 119·10; *P* = 0·038), T4 status, R1 resection and venous vessel invasion were associated with local recurrence in stage II, whereas attendance of ESSQS‐qualified surgeons was not an independent factor associated with recurrence in stage III (HR 0·53, 95 per cent c.i. 0·14 to 1·85; *P* = 0·317) (*Fig*. [3](#bjs550263-fig-0003){ref-type="fig"} *b,c*).

![Association between intervention by ESSQS‐qualified surgeons and local recurrence‐free survival in patients with stage II and III cancers **a** Kaplan--Meier analysis of local recurrence‐free survival (RFS) in patients with stage II and III colorectal cancer operated on by ESSQS‐certified or non‐ESSQS‐qualified surgeons. *P* = 0·092 (log rank test). **b,c** Cox regression analysis of local recurrence. Hazard ratios are shown with 95 per cent confidence intervals for each risk factor for patients with stage II (**b**) and stage III (**c**) disease. \**P* \< 0·050. ESSQS, Endoscopic Surgical Skill Qualification System; LND, lymph node dissection; Por, poorly differentiated; Muc, mucinous.](BJS5-4-486-g003){#bjs550263-fig-0003}

Relationship between institutional heterogeneity and postoperative complications {#bjs550263-sec-0014}
--------------------------------------------------------------------------------

The rate of postoperative complications was related to the proportion of procedures that ESSQS surgeons participated in (*R* ^2^ = 0·39, *P* = 0·041), but had no relationship with the number of beds, annual volume of colorectal cancer procedures or number of surgeons (data not shown). Furthermore, the proportion of colorectal operations that were performed laparoscopically increased along with the proportion of operations that ESSQS surgeons participated in (*R* ^2^ = 0·57, *P* = 0·007) (*Fig*. [4](#bjs550263-fig-0004){ref-type="fig"}).

![Correlation between the proportion of procedures attended by ESSQS‐qualified surgeons and the postoperative complication rate, and the proportion of colorectal procedures done laparoscopically **a** Postoperative complication rate in each institution. *R* ^2^ = 0·29, *P* = 0·041 (linear regression). **b** Proportion of colorectal procedures done laparoscopically. *R* ^2^ = 0·57, *P* = 0·007 (linear regression). ESSQS, Endoscopic Surgical Skill Qualification System.](BJS5-4-486-g004){#bjs550263-fig-0004}

Discussion {#bjs550263-sec-0015}
==========

In this study, the superiority of attendance over non‐attendance of ESSQS‐qualified surgeons in laparoscopic colorectal resection was apparent in terms of duration of surgery, intraoperative and postoperative complications (Clavien--Dindo grade III or above) rates, reoperation rate and length of postoperative hospital stay. More difficult cases were reported in the ESSQS group, such as rectal cancer, patients with obstruction and high ASA grade. The procedures performed by ESSQS‐qualified surgeons were also considered to be more advanced, such as rectal resection and D3 lymph node dissection. Nevertheless, the ESSQS group had significantly shorter duration of surgery and postoperative hospital stay, lower intraoperative and postoperative complication rates, and a lower reoperation rate than the non‐ESSQS group. Additionally, the differences in duration of surgery and intraoperative complication rate were significant for advanced procedures such as anterior rectal resection. These results support the supposition that the ESSQS‐qualified surgeons have improved laparoscopic surgical skills and provide better short‐term outcomes.

These findings were further validated in the propensity score‐matched cohort. Similarly, the mean duration of surgery (226 min), blood loss (48·7 ml), conversion rate (2·1 per cent), postoperative complication rate (Clavien--Dindo grade III or above, 4·7 per cent) and reoperation rate (1·6 per cent) in the ESSQS group were comparable to the respective values of 211 min, 30 ml, 5·4 per cent, 4·6 per cent (Common Terminology Criteria for Adverse Events version 3.0 grade 3 or above) and 1·7 per cent reported in the Japan Clinical Oncology Group (JCOG) 0404 study, a nationwide RCT investigating the safety of laparoscopic colectomy performed by expert surgeons[7](#bjs550263-bib-0007){ref-type="ref"}.

Among patients with stage II and III disease, local recurrence was improved in the ESSQS group compared with that in the non‐ESSQS group. In particular, non‐attendance of ESSQS‐qualified surgeons was one of the independent risk factors for local recurrence in patients with stage II disease. However, in patients with stage III disease, the local recurrence rate was similar in the two groups, although these long‐term outcomes should be validated in larger studies. The recurrence‐free survival rate of patients with stage II--III cancers in the ESSQS group was 76·1 (95 per cent c.i. 71·0 to 80·6) per cent, which is comparable to the rate of 79 (75·6 to 82·6) per cent in the JCOG 0404 study with similar patient distributions[8](#bjs550263-bib-0008){ref-type="ref"}.

The present study is representative of real‐world practice. In 2010, laparoscopic colorectal surgery was performed in more than ten colorectal procedures per year in the 13 institutions affiliated to the Hokkaido University, although only ten of these institutions agreed to participate in the study. Therefore, there was a slight bias in the selection of institutions. A number of studies[9](#bjs550263-bib-0009){ref-type="ref"}, [10](#bjs550263-bib-0010){ref-type="ref"} have reported that hospital case volume or surgeon volume is associated with short‐ and long‐term outcomes in some types of cancer, including colorectal cancer. However, in the present study, the postoperative complication rate was not associated with the number of beds, annual volume of colorectal cancer procedures or number of surgeons, but was related to the attendance of ESSQS‐qualified surgeons.

This study has some other limitations. As it was not a prospective study or an RCT, there were several differences in patients\' backgrounds. Furthermore, it was a regional study limited to Hokkaido Prefecture rather than nationwide, and the numbers of attending ESSQS‐qualified surgeons and advanced rectal cancers were small. Over 30 per cent of patients with low rectal cancer undergo low anterior resection using the laparoscopic approach in Japan[11](#bjs550263-bib-0011){ref-type="ref"}. However, both the short‐term safety of this procedure in the general setting and the long‐term safety have not been well established[12](#bjs550263-bib-0012){ref-type="ref"}, [13](#bjs550263-bib-0013){ref-type="ref"}, [14](#bjs550263-bib-0014){ref-type="ref"}, [15](#bjs550263-bib-0015){ref-type="ref"}. Clarifying the value of ESSQS‐qualified surgeons in the performance of safe laparoscopic rectal resection is one of the issues that needs to be resolved. Finally, the circumstances surrounding laparoscopic colorectal resection are changing. The rate of laparoscopic surgery has increased year on year compared with that of open surgery, and young surgeons have more opportunity to learn and perform laparoscopic surgery safely[16](#bjs550263-bib-0016){ref-type="ref"}. In the future, nationwide studies will help to clarify fully the relevance of the ESSQS in colorectal surgical laparoscopic practice.
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